{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:18:31Z","timestamp":1792466311557,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijantimicag.2014.12.031","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T03:19:20Z","timestamp":1424056760000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Tetracyclines for multidrug-resistant Acinetobacter baumannii infections"],"prefix":"10.1016","volume":"45","author":[{"given":"Matthew E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos Z.","family":"Vardakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kapaskelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Triarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos S.","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0170","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(08)70279-2","article-title":"Current control and treatment of multidrug-resistant Acinetobacter baumannii infections","volume":"8","author":"Karageorgopoulos","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0185","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2009.06.021","article-title":"Minocycline\u2014an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii","volume":"34","author":"Bishburg","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IPC.0b013e31828bbb82","article-title":"Use of intravenous minocycline for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) and resistant Gram-negative organisms: experience in a tertiary care hospital","volume":"22","author":"Bishburg","year":"2014","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0885066610377975","article-title":"Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"25","author":"Chan","year":"2010","journal-title":"J Intensive Care Med"},{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2014.12.031_bib0205","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1093\/cid\/ciu593","article-title":"Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections","volume":"59","author":"Goff","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ipc.0b013e318159d595","article-title":"Minocycline therapy for traumatic wound infections caused by the multidrug-resistant Acinetobacter baumannii\u2013Acinetobacter calcoaceticus complex","volume":"16","author":"Griffith","year":"2008","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0215","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1345\/aph.1H353","article-title":"Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit","volume":"40","author":"Holloway","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/IPC.0b013e318245d50a","article-title":"A stewardship approach to combating multidrug-resistant Acinetobacter baumannii infections with minocycline","volume":"20","author":"Jankowski","year":"2012","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0225","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3760\/cma.j.issn.0366-6999.20132047","article-title":"A combination regimen of meropenem, cefoperazone\u2013sulbactam and minocycline for extensive burns with pan-drug resistant Acinetobacter baumannii infection","volume":"127","author":"Ning","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0230","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1093\/cid\/ciu594","article-title":"Carbapenem-resistance in Gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center","volume":"59","author":"Pogue","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0235","first-page":"185","article-title":"Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii [in Chinese]","volume":"36","author":"Wang","year":"2014","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0240","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s00134-003-1811-2","article-title":"Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"29","author":"Wood","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0245","first-page":"2847","article-title":"Cefoperazone\u2013sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections","volume":"92","author":"Shi","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0250","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0255","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10096-014-2124-9","article-title":"Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review","volume":"33","author":"Poulikakos","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3343\/kjlm.2007.27.2.111","article-title":"In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii","volume":"27","author":"Sung","year":"2007","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkm178","article-title":"In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates","volume":"60","author":"Tan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0270","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijantimicag.2010.04.011","article-title":"Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates","volume":"36","author":"Kiratisin","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0275","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2125.1991.tb03920.x","article-title":"Penetration of minocycline into lung tissues","volume":"32","author":"Naline","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1378\/chest.78.2.304","article-title":"Tissue levels of doxycycline in the human lung and pleura","volume":"78","author":"Thadepalli","year":"1980","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0285","first-page":"276","article-title":"Sputum and plasma doxycycline concentrations after a single oral 600mg doxycycline dose in patients with chronic bronchitis","volume":"62","author":"Marlin","year":"1981","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048494","article-title":"Penetration of minocycline hydrochloride into lung tissue and sputum","volume":"47","author":"Watanabe","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0300","unstructured":"Rempex Pharmaceuticals Inc MINOCIN\u00ae package insert. San Diego CA: Rempex Pharmaceuticals; 2013."},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0305","series-title":"DOXYCLIN\u00ae package insert","year":"2008"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0310","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1093\/cid\/ciu613","article-title":"A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections","volume":"59","author":"Ritchie","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0315","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/AAC.00922-07","article-title":"Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model","volume":"52","author":"Bowker","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0320","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1099\/jmm.0.46747-0","article-title":"The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"55","author":"Falagas","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0325","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/cid\/ciu706","article-title":"Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options","volume":"59","author":"Castanheira","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.031_bib0330","first-page":"376","article-title":"Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents","volume":"51","author":"Hawley","year":"2007","journal-title":"Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T02:29:54Z","timestamp":1717727394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0924857915000606"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.031","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclines for multidrug-resistant Acinetobacter baumannii infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}